This message was sent to AIM, Health Systems, INE, IAP, LHD Health Officers, LHD Medical Directors, MACI, MACI 2, PH Imms Leads, MCIR Regional Contacts, COVID-19 Vaccine Providers, and Imms All Staff. Apologies for any duplication.

Hello Immunization Partners, 

Please share the following information with providers in your jurisdiction. 

The Michigan Department of Health and Human Services (MDHHS) would like to make you aware that Immunize.org has published two new standing orders:, one for Nirsevimab RSV preventive antibody for infants, and one for RSV vaccination during pregnancy. Please be aware that the nirsevimab standing order is for the 2023-2024 RSV season only. Prior to use, these standing orders should be reviewed and signed by your Medical Director.

For additional information on RSV please see the resources listed below:

• For Healthcare Professionals: RSV (Respiratory Syncytial Virus) | CDC
• Healthcare Providers: RSV Vaccination for Pregnant People | CDC
• Healthcare Providers: RSV Immunization for Children 19 Months and Younger | CDC
• ACIP and AAP Recommendations for Nirsevimab | Red Book Online | American Academy of Pediatrics

Please email checcimms@michigan.gov with any questions.

Thank you for all you do! 

Your Immunization Outreach and Education Team,
Alyssa, Andrea, Dianne, Heidi, Lisa, and Sarah